West Hartford, CTNCT07149740Now EnrollingIRB Ready

Retinal Disease Clinical Trial in West Hartford, CT

Access cutting-edge retinal disease treatment through this clinical trial at a research site in West Hartford. Study-provided care at no cost to qualified participants.

Sponsored by Optos, PLC

Quick Self-Assessment

See if you qualify for this West Hartford location

Preparing your pre-screening questions…

Expert Care in West Hartford

Access retinal disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retinal disease treatment provided free

Apply for This West Hartford Location

Check if you qualify for this retinal disease clinical trial in West Hartford, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to West Hartford

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit West Hartford site if eligible
  4. 4Begin participation

About This Retinal Disease Study in West Hartford

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes

Sponsor: Optos, PLC

Who Can Participate

Exclusion Criteria

Participants 22 years of age or older on the date of informed consent
Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
BCVA 20/400 or better in the study eye
Participants presenting at the site with retinal disease
Diagnosis of some type of retinal pathology by investigator, may include, but not limited to: Macular Degeneration (including participants with drusen and geographic atrophy and choroidal neovascularization), Diabetic Macular Edema, Diabetic Retinopathy, Macular Hole, Epiretinal Membrane, Central Serous Retinopathy and others Exclusion Criteria for Retinal Disease Group
Participants unable to tolerate ophthalmic imaging
Participants not able to obtain acceptable OCT images due to ocular media opacity or other reasons
Participant has a condition or is in a situation which the investigator feels may put the participant at significant risk, may confound the study results, or may interfere significantly with the participant's participation in the study
Presence of glaucoma or any ocular pathology other than a retinal pathology in the study eye as determined by self-report and/or investigator assessment at the study visit; Inclusion Criteria for Glaucoma Group
Participants 22 years of age or older on the date of informed consent
Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
BCVA 20/40 or better in the study eye
History of Visual field defects within the previous year from the study visit or measured the day of the study visit consistent with glaucomatous optic nerve damage with at least one of the following two findings:
On pattern deviation (PD), there exists a cluster of 3 or more points in an expected location of the visual field depressed below the 5% level, at least 1 of which is depressed below the 1% level;
Glaucoma hemi-field test "outside normal limits."
Glaucomatous optic nerve damage as evidenced by any of the following optic disc or retinal nerve fiber layer structural abnormalities:
Diffuse thinning, focal narrowing, or notching of the neuroretinal rim, especially at the inferior or superior poles with or without disc hemorrhage;
Optic disc neural rim asymmetry of the two eyes consistent with loss of neural tissue Exclusion Criteria for Glaucoma Group
Participants unable to tolerate ophthalmic imaging
Participants not able to obtain acceptable OCT images due to ocular media opacity or other reasons
Participant has a condition or is in a situation which the investigator feels may put the participant at significant risk, may confound the study results, or may interfere significantly with the participant's participation in the study
No reliable visual field test result within the previous year from the study visit, defined as fixation losses \> 33% or false positives \> 33%, or false negatives \> 33% in the study eye
Presence of any ocular pathology except glaucoma in the study eye Inclusion Criteria for Corneal Group 1\. Participants 22 years of age or older on the date of informed consent 2. Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Participants presenting at the site with corneal disease, for example but not limited to, corneal disorders due to contact lens wear, post-refractive surgery, dry eye, keratoconus 4. Participant is able to comply with the study procedures. Exclusion Criteria for Corneal Group
Participants unable to tolerate ophthalmic imaging
Participant has a condition or is in a situation which the investigator feels may put the participant at significant risk, may confound the study results, or may interfere significantly with the participant's participation in the study
Participant with ocular media not sufficiently clear to obtain acceptable OCT images. Inclusion Criteria for Normal Group
Participants 22 years of age or older on the date of informed consent
Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
Participants presenting at the site with normal eyes (Cataracts, LASIK, PRK, and peripheral pathology that does not affect the posterior pole region, for example lattice and peripheral drusen, are allowed).
BCVA 20/40 or better (each eye)
Participant is able to comply with the study procedures Exclusion Criteria for Normal Group
Participants unable to tolerate ophthalmic imaging
Participant has a condition or is in a situation which the investigator feels may put the participant at significant risk, may confound the study results, or may interfere significantly with the participant's participation in the study
Participant with ocular media not sufficiently clear to obtain acceptable OCT images
History of leukemia, dementia or multiple sclerosis

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in West Hartford?

Yes, this clinical trial (NCT07149740) has an active research site in West Hartford, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retinal Disease Treatment Options in West Hartford, CT

If you're searching for retinal disease treatment options in West Hartford, CT, this clinical trial (NCT07149740) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our West Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retinal disease clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in West Hartford, CT

See all essential tremor clinical trials recruiting in West Hartford — not just this study.

Browse Essential Tremor Trials in West Hartford →

Browse More Trials by Condition

Essential Tremor TrialsAnkylosing Spondylitis TrialsDiabetic Retinopathy TrialsRetinitis Pigmentosa TrialsAll Conditions →

Ready to Join in West Hartford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · West Hartford, CT